Semaglutide and walking capacity in people with symptomatic lower extremity artery disease and type 2 diabetes: STRIDE Japanese cohort study

Semaglutide and walking capacity in people with symptomatic lower extremity artery disease and type 2 diabetes: STRIDE Japanese cohort study

The STRIDE trial demonstrated that among Japanese patients with type 2 diabetes and intermittent claudication, the addition of semaglutide to standard care improved walking capacity and lower extremity artery disease (LEAD)-related quality of life compared with placebo, consistent with the overall trial population, according to a study presented by Dr. Masato Nakamura, Toho University Ohashi Medical Center, Japan, in the Late Breaking Clinical Trials session at the 90th Annual Scientific Meeting of the Japanese Circulation Society.

In the STRIDE trial, 792 patients with type 2 diabetes and Fontaine class IIa intermittent claudicat...
Continue reading this article
Select an option below:
Go beyond the guidelines
A portal site of complex catheter intervention techniques
About TCROSS NEWS Global

TCROSS NEWS Global is an online medical journal that provides valuable information on Cardiovascular medicine to medical professionals worldwide.
We bring you the latest findings and trends in all areas of cardiovascular medicine. Please register and subscribe for unlimited access to quality Cardiovascular News!

Introducing the main contents
Conference Reports
Conference Reports
Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!
Complex PCI Cases
Complex PCI Cases
Features case reports on patients with complex lesions encountered in daily clinical practice.
Live Demonstration Courses
Live Demonstration CoursesComing soon
In this section you will find live videos of catheter interventions for complex lesions.
What is TCROSS NEWS GLOBAL?
TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
This website is automatically translated using Google Translate.